Moreover, USP7 appears to play a key role in lung cancers resistant to Paclitaxel through the regulation of two proteins involved in cell mitosis: Serine/threonine-protein kinase or polo-like kinase 1 (PLK1) and BUB3 Mitotic Checkpoint Protein (BUB3). Here, PLK1 is linked to lung carcinoma.